Yet in June 2019, they advised that applications and interest from participants were "higher than expected" and would lead to "time savings" with completion of the trial expected by Q2 2020.
Pity help anyone that takes any sort of guidance on timelines from this company.
Let me think..... was that June 2019 update right before the MXCOD options expiry? Could it be that announcement was designed to fool option holders in to converting those options?
Ann: Patients Begin Treatment in Clinical Trial of CogniCann, page-29
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $13.77M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.5¢ | 29.0¢ | $7.701K | 25.66K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 16444 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 44236 | 1 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| RGT (ASX) Chart |